微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-21-137081 Act: 34 Size: 473 KB 网页链接
$Myomo(MYO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-21-137087 Act: 34 Size: 67 KB 网页链接
$Myomo(MYO)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-21-136907 Act: 34 Size: 225 KB 网页链接
$Myomo(MYO)$ PRE 14A Other preliminary proxy statements Accession Number: 0001193125-21-119528 Act: 34 Size: 474 KB 网页链接
$Myomo(MYO)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001193125-21-107712 Act: 34 Size: 133 KB 网页链接
$Myomo(MYO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-21-012068 Act: 34 Size: 11 MB 网页链接
$Myomo(MYO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-21-076224 Act: 34 Size: 173 KB 网页链接
$Myomo(MYO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000895421-21-000280 Act: 34 Size: 12 KB 网页链接
$Myomo(MYO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-024070 Act: 34 Size: 89 KB 网页链接
$Myomo(MYO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-21-023238 Act: 34 Size: 57 KB 网页链接